Asian Spectator

Men's Weekly

.

PYC'S FOURTH DRUG CANDIDATE HAS DISEASE-MODIFYING POTENTIAL IN POLYCYSTIC KIDNEY DISEASE

  • Written by PR Newswire Asia - Asian Spectator
  • PYC has developed a new drug candidate for the >5 million people worldwide[1] with Polycystic Kidney Disease (PKD)
  • This drug candidate has demonstrated efficacy in human models derived from the kidneys of patients with end-stage renal failure due to PKD[2]
  • PKD is a life-changing disease affecting 1 in every 1,000 people[3]
  • Half of the patient...

More Articles ...

  1. Ipsen and Medison Pharma Announce Health Canada Approval of Bylvay™ (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC)

Magazine

‘Polyworking’: Ketika 1 pekerjaan tak lagi cukup

● Kenaikan harga kebutuhan setiap tahun memaksa banyak orang mencari pekerjaan tambahan.● Pekerjaan tambahan yang dimaksud tidak hanya sampingan, tapi dilakukan dengan intensitas yang hamp...

Saat kesalahan karya ilmiah dibiarkan: Penerbit tetap untung, publik yang rugi

● Kesalahan di jurnal ilmiah bisa berdampak besar, tetapi sering lambat dikoreksi.● Sistem penerbitan akademik yang berorientasi keuntungan acap abai akan kesalahan.● Diperlukan refo...

Indonesia pimpin Dewan HAM PBB: Prestise global di tengah problem domestik

Logo PBB dan bendera Indonesia.hapelinium/Shutterstock● Kepemimpinan Indonesia di Dewan HAM PBB sangat ironis di tengah rapor merah penegakan HAM dalam negeri.● Indonesia mencoba menjadi p...